New Cousteau-Linked...
Health Care: Health Services
Bio-Reference Labs Inc. (BRLI: NASDAQ)
$19.26 0.88 | 4.79%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 14.50 | 70.50 | 17.70 |
| P/E High - Last 5 Yrs | 35.40 | 88.50 | 67.70 |
| P/E Low - Last 5 Yrs | 11.80 | 21.80 | 12.50 |
| Beta | 0.89 | 0.68 | 0.98 |
| Price to Sales (TTM) | 0.87 | 1.54 | 1.42 |
| Price to Book (MRQ) | 2.63 | 2.30 | 2.41 |
| Price to Tangible Book (MRQ) | 3.11 | -8.10 | 5.08 |
| Price to Cash Flow (TTM) | 10.00 | 15.00 | 9.80 |
| Price to Free Cash Flow (TTM) | 24.90 | 54.90 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.60 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.40 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | -2.58 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 88.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 23.20 | 12.60 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 22.00 | 2.90 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 21.52 | 15.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | -7.80 | -0.70 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | -7.80 | -0.70 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | 23.24 | -13.79 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | 27.63 | 9.33 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 2.00 | 1.20 | 1.10 |
| Current Ratio (MRQ) | 2.50 | 1.40 | 1.60 |
| LT Debt to Equity (MRQ) | 0.05 | 0.70 | 0.82 |
| Total Debt to Equity (MRQ) | 0.18 | 0.80 | 0.96 |
| Interest Coverage (TTM) | 37.30 | 2.60 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 50.60 | 45.20 | 46.90 |
| Gross Margin - 5 Yr Avg | 51.10 | 45.50 | 47.70 |
| EBITD Margin (TTM) | 13.60 | 17.80 | 18.90 |
| EBITD - 5 Yr Avg | 12.92 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | 10.90 | 3.70 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | 10.40 | 11.30 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.06 | 0.01 | 0.09 |
| Net Profit Margin - 5 Yr Avg | 5.90 | 6.10 | 7.00 |
| Return on Assets (TTM) | 12.40 | 0.60 | 3.10 |
| Return on Assets - 5 Yr Avg | 10.90 | 4.80 | 2.50 |
| Return on Investment (TTM) | 17.50 | 0.90 | 7.90 |
| Return on Investment - 5 Yr Avg | 16.30 | 6.60 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 240,731.00 | 213,809.00 | 449,376.00 |
| Net Income/Employee (TTM) | 14,659.00 | 1,800.00 | 39,003.00 |
| Receivable Turnover (TTM) | 4.20 | 5.70 | 7.60 |
| Inventory Turnover (TTM) | 32.80 | 23.30 | 8.30 |
| Asset Turnover (TTM) | 2.10 | 0.80 | 0.40 |
Portfolios with BRLI
- Portfolio NameUser Type
- Contributor10 Small-Cap Stocks Poised ...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorSmall-Caps With Big Potential
- UserSPECULATIVE
- ContributorEarnings Short Squeeze Play...
- ContributorThree Growth Stocks for a B...
- UserRFW2
- ContributorTop 5 Small-Cap Stocks: Aug...
Latest BRLI Headlines from TheStreet
- Jarden, Bio-Reference Labs: Time to Buy? 03.15.12 | 03:03 pm
- Time To Jump Into Jarden, Bio-Reference Labs
03.15.12 | 05:03 am - 10 Small-Cap Stocks Poised to Rise, History Shows (Update1) 03.13.12 | 10:03 am
- Bio-Reference Labs Inc. Stock Upgraded (BRLI) 02.01.12 | 06:02 am
- Bio-Reference Labs Inc. Stock Downgraded (BRLI) 11.28.11 | 05:11 am
- Bio-Reference Rises On Unusually High Volume (BRLI) 11.08.11 | 01:11 pm
- Bio-References Not Done Growing, Says CEO 09.09.11 | 05:09 am
- 5 Earnings Short-Squeeze Plays 08.23.11 | 01:08 pm
- Bio-Reference Reaches New 52-Week High (BRLI) 05.26.11 | 10:05 am
- Heavily Shorted Stocks That Could Pop on Earnings 05.24.11 | 07:05 am
Press Releases for BRLI
- BioReference Laboratories, Inc. Announces Earnings Date For Second Quarter Fiscal Year 2012 - Business Wire 05.31.12 | 08:05 am
- Bio-Reference Laboratories, Inc. Announces Record First Quarter Revenue, Earnings And Cash Flow From Operations - Business Wire 03.01.12 | 08:03 am
- Bio-Reference Laboratories, Inc. Announces Earnings Date For First Quarter Fiscal Year 2012 - Business Wire 02.23.12 | 08:02 am
- BioReference Announces 2012 Annual Meeting Date - Business Wire 02.08.12 | 03:02 pm
- BioReference To Launch Groundbreaking Solid Tumor Genotyping Test Through Its GenPath Oncology Laboratory - Business Wire 01.26.12 | 08:01 am
- BioReference Laboratories, Inc. Announces Contract With Corizon, Inc. To Provide Correctional Healthcare Laboratory Services - Business Wire 01.12.12 | 08:01 am
- Bio-Reference Laboratories, Inc. Announces Record Revenues, Earnings And Cash Flow For Fourth Quarter And Full Fiscal Year - Business Wire 12.08.11 | 08:12 am
- BioReference Laboratories, Inc. Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2011 - Business Wire 12.07.11 | 02:12 pm
- BioReference Laboratories, Inc. To Speak At The Oppenheimer 22nd Annual Healthcare Conference - Business Wire 12.07.11 | 08:12 am
- Bio-Reference Laboratories, Inc. And McKesson Specialty Health’s Onmark GPO Execute Purchasing Agreement - Business Wire 11.22.11 | 02:11 pm
Partner Headlines for BRLI
- Bio Reference Labs, Quest Diagnostics Inc., Laboratory Corp. Of America: Diagnosis Profits - Seeking Alpha 03.05.12 | 08:03 am
- 10 Highly Shorted, Rallying Stocks With Strong Sources Of Profitability - Seeking Alpha 02.02.12 | 08:02 am
- Bio-Reference: Loads Of Dirty Laundry - Seeking Alpha 11.13.11 | 09:11 am
- Jefferies Places Bio-References Labs Under Review - Benzinga 11.11.11 | 09:11 am
- UPDATE: StreetSweeper Posts Negative Article on Bio-Reference - Benzinga 11.10.11 | 01:11 pm
- Questions Raised Over Bio-Reference Labs - Benzinga 11.01.11 | 01:11 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 09.29.11 | 09:09 am
- Upgrades, Downgrades, Initiations and Other Changes for Friday - Seeking Alpha 05.27.11 | 04:05 pm
- 10 Health Care Companies You Can Be Proud to Own - Benzinga 04.08.11 | 06:04 pm
- Benzinga’s Volume Movers (MNTA, HAIN, BRLI, PAAS) - Benzinga 08.26.10 | 01:08 pm
